quantisnow
FeedTopReportsPricing
⌘K
Live feed
10:13:57·15d
SECFiling
Castle Biosciences Inc. logo

SEC Form DEFA14A filed by Castle Biosciences Inc.

CSTL· Castle Biosciences Inc.
Health Care
Original source

Companies

  • CSTL
    Castle Biosciences Inc.
    Health Care

Recent analyst ratings

  • Dec 14UpdateGuggenheim$25.00
  • Jan 5UpdateScotiabank$54.00
  • Jan 7UpdateStephens & Co.$59.00
  • Nov 9UpdateSVB Leerink$75.00
  • Jul 14UpdateSVB Leerink$85.00

Related

  • INSIDER10h
    Pres. & Chief Exec. Officer Maetzold Derek J exercised 550 shares at a strike of $2.39 and sold $104,709 worth of shares (4,172 units at $25.10) as part of a pre-agreed trading plan (SEC Form 4)
  • PR2d
    Castle Biosciences to Present New Data Demonstrating DecisionDx®-Melanoma's Ability to Identify Patients with Greater Risk of Recurrence and Poor Outcomes Within Early-Stage Melanoma at EADO and ACMS
  • PR8d
    Castle Biosciences to Release First Quarter 2026 Financial Results and Host Webcast on Wednesday, May 6, 2026
  • PR13d
    Castle Biosciences Earns 2026 USA TODAY Top Workplaces Award for Fifth Consecutive Year
  • INSIDER15d
    SEC Form 4 filed by Maetzold Derek J
  • SEC15d
    SEC Form DEF 14A filed by Castle Biosciences Inc.
  • INSIDER24d
    SEC Form 4 filed by Maetzold Derek J
  • INSIDER24d
    SEC Form 4 filed by Cotton Rodney
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022